BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 356708)

  • 1. Cardiac metabolism in myocardial ischaemia.
    Ylikahri RH
    Ann Clin Res; 1977 Jun; 9(3):102-11. PubMed ID: 356708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormalities of myocardial lipid metabolism and advances of drug intervention in acute myocardial ischemia].
    Hu ZW
    Sheng Li Ke Xue Jin Zhan; 1984 Jan; 15(1):35-40. PubMed ID: 6151251
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial ischemia (second of three parts).
    Hillis LD; Braunwald E
    N Engl J Med; 1977 May; 296(18):1034-41. PubMed ID: 321964
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucose-insulin-potassium therapy for acute myocardial infarction: what goes around comes around.
    Gnaim CI; McGuire DK
    Am Heart J; 2004 Dec; 148(6):924-30. PubMed ID: 15632873
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose-insulin-potassium, free fatty acids and acute myocardial infarction in man.
    Russell RO; Rogers WJ; Mantle JA; McDaniel HG; Rackley CE
    Circulation; 1976 Mar; 53(3 Suppl):I207-9. PubMed ID: 1253362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring of NEFA and other biochemical parameters in acute myocardial infarct].
    Abrate M; Castelletti GC; Aillon C; Angelino PF
    G Ital Cardiol; 1979; 9(8):799-805. PubMed ID: 398816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of baboons in studies of acute myocardial infarction and effects of infusions of glucose, insulin and potassium (GIK).
    Bruyneel K; Opie LH
    Acta Med Scand Suppl; 1976; 587():65-9. PubMed ID: 1062133
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction.
    Rackley CE; Russell RO; Rogers WJ; Mantle JA; McDaniel HG; Papapietro SE
    Am Heart J; 1981 Dec; 102(6 Pt 1):1038-49. PubMed ID: 7032266
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
    Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of "polarizing" solutions (glucose, potassium, insulin) in acute coronary insufficiency. Review of the literature and the authors' data].
    Chernov AZ; Gerchikova TN
    Ter Arkh; 1969 Nov; 41(11):8-13. PubMed ID: 4916348
    [No Abstract]   [Full Text] [Related]  

  • 11. The polarizing treatment in acute myocardial infarction. A thermodynamic and metabolic approach.
    Sodi-Pallares D; Bisteni A; Ponce de Leon J; Ariza D; Gonzalez Ahumada M; Medrano GA
    Agressologie; 1972; 13(6):391-405. PubMed ID: 4652241
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size.
    Opie LH
    Am J Cardiol; 1975 Dec; 36(7):938-53. PubMed ID: 1106170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of reduction of myocardial free fatty acid metabolism relative to that of glucose on the ischemic injury during experimental coronary artery occlusion in dogs.
    Mjos OD
    Acta Med Scand Suppl; 1976; 587():29-34. PubMed ID: 1062130
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose, insulin, and potassium for metabolic support in acute myocardial infarction: is the jury still out?
    Broder HJ; Nesto RW
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S44-50. PubMed ID: 17224877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery ligation in the baboon as a model of acute myocardial infarction: failure of glucose, potassium, and insulin treatment to influence mitochondrial metabolism and energetics.
    Lochner A; Opie LH; Gray A; Owen P; Bruyneel K; van der Walt JJ; Kotze JC; Gevers W
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():685-91. PubMed ID: 4806671
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential protective value of enhanced myocardial carbohydrate utilisation with reduced free fatty acid uptake after UK 25842 in patients with coronary artery disease [proceedings].
    Atkinson L; Bergman G; Jackson N; Jewitt DE; Metcalfe JM
    Br J Pharmacol; 1979 Jul; 66(3):444P. PubMed ID: 526734
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease.
    Stanley AW; Moraski RE; Russell RO; Rogers WJ; Mantle JA; Kreisberg RA; McDaniel HG; Rackley CE
    Am J Cardiol; 1975 Dec; 36(7):929-37. PubMed ID: 1199950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial energy metabolism.
    Näveri L; Näveri H; Härkönen M
    Ann Chir Gynaecol; 1987; 76(1):3-11. PubMed ID: 3296930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative changes in free-fatty-acid and glucose utilisation by ischaemic myocardium after coronary-artery occlusion.
    Owen P; Thomas M; Opie L
    Lancet; 1969 Jun; 1(7607):1187-90. PubMed ID: 4181841
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of mannitol, hyaluronidase and glucose-insulin-potassium in the treatment of acute myocardial infarction (author's transl)].
    Hirzel HO
    Herz; 1981 Apr; 6(2):98-106. PubMed ID: 6785178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.